Endothelial mitochondrial homeostasis in the development and progression of atherosclerosis
Frontiers in Cardiovascular Medicine · 12.06.2026 · 13
DOI: 10.3389/fcvm.2026.1813122 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 12.06.2026. Verfasst von Naznin Sultana Remex und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Physiology, Louisiana State University Health, Shreveport, LA, United States. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 215 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Vascular endothelial cells (ECs) play a critical role in vascular functional homeostasis, and endothelial dysfunction activates signaling pathways that drive the development and progression of atherosclerosis. Mitochondria in ECs play an essential signaling role in regulating redox balance, calcium signaling, metabolic signaling, and inflammatory responses. Disruption of mitochondrial functional homeostasis by atherogenic stimuli leads to excessive mitochondrial reactive oxygen species production, altered mitochondrial dynamics, defective mitophagy, and mitochondrial DNA damage. These mitochondrial defects in ECs reduce nitric oxide bioavailability through eNOS uncoupling, destabilize endothelial junctional complexes, and promote endothelial activation. Additionally, damaged mitochondria release mitochondrial danger-associated molecular patterns contributing to the activation of inflammation and redox-sensitive signaling pathways in ECs. In this review, we delineated the mechanistic links between endothelial mitochondrial dysfunction and the pathological features of atherosclerosis. We highlight the contribution of mitochondrial signaling to the regulation of oxidative stress, innate immune activation, and endothelial barrier disruption. We also discussed emerging therapeutic strategies targeting mitochondria-associated signaling pathways, including modulation of mitochondrial dynamics, mitophagy, redox signaling, and mitochondria-targeted drug delivery. Together, we provide insights into the role of endothelial mitochondria in atherosclerotic disease progression and compelling targets for mechanism-based therapeutic intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular and Cellular Physiology, Louisiana State University Health, Shreveport, LA, United States.
- Department of Pathology and Translational Pathobiology, Louisiana State University Health, Shreveport, LA, United States.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Remex, N. S., Miah, M. S., Islam, T., Aishwarya, R., Sinha, M. H., Dhar, P., Dhaou, C. B., Orr, A. W., & Bhuiyan, M. S. (2026). Endothelial mitochondrial homeostasis in the development and progression of atherosclerosis. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1813122
Vancouver
Remex NS, Miah MS, Islam T, Aishwarya R, Sinha MH, Dhar P, et al. Endothelial mitochondrial homeostasis in the development and progression of atherosclerosis. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1813122
BibTeX
@article{Remex2026,
author = {Remex, Naznin Sultana and Miah, Md Sakil and Islam, Tamjid and Aishwarya, Richa and Sinha, Md Hasif and Dhar, Proma and Dhaou, Cyrine Ben and Orr, A Wayne and Bhuiyan, Md Shenuarin},
title = {Endothelial mitochondrial homeostasis in the development and progression of atherosclerosis},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1813122}
}
EUVIMED